Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.720
-0.010 (-0.58%)
At close: Dec 5, 2025, 4:00 PM EST
1.740
+0.020 (1.16%)
After-hours: Dec 5, 2025, 6:49 PM EST
Climb Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -50.75 | -73.9 | -35.12 | -45.24 | -47.48 | -20.67 | |
| Asset Writedown & Restructuring Costs | - | 51.66 | 0.18 | - | - | 9.16 | |
| Loss (Gain) From Sale of Investments | -2.29 | -0.76 | -2.33 | -0.18 | 0.37 | - | |
| Stock-Based Compensation | 8.67 | 5.56 | 12.81 | 6.99 | 3.74 | 0.71 | |
| Other Operating Activities | 0.26 | 0.18 | 0.1 | 0.85 | 11.47 | -0.36 | |
| Change in Accounts Payable | 0.01 | -1.14 | -0.69 | -0.65 | 0.32 | -0.02 | |
| Change in Other Net Operating Assets | -0.21 | 2.84 | 4.45 | 0.86 | -4.49 | -2.91 | |
| Operating Cash Flow | -44.24 | -15.56 | -20.6 | -37.37 | -36.07 | -14.1 | |
| Cash Acquisitions | - | -4.65 | - | - | - | 8.28 | |
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.2 | |
| Investment in Securities | -75.93 | -111.45 | 68.98 | 34.44 | -114.97 | - | |
| Investing Cash Flow | -76.11 | -121.09 | 68.98 | 34.44 | -114.97 | 8.08 | |
| Issuance of Common Stock | 0.29 | 130.98 | 0.84 | - | 83.29 | - | |
| Other Financing Activities | -0.25 | -0.25 | - | - | - | - | |
| Financing Cash Flow | 0.04 | 130.73 | 0.84 | - | 177.23 | 4.93 | |
| Foreign Exchange Rate Adjustments | -0.06 | 0.04 | 0.3 | -0.41 | 0.25 | 0.36 | |
| Net Cash Flow | -120.37 | -5.88 | 49.53 | -3.34 | 26.44 | -0.74 | |
| Levered Free Cash Flow | -24.98 | -9.54 | 3.46 | -20.51 | -25.3 | -6.57 | |
| Unlevered Free Cash Flow | -24.98 | -9.54 | 3.46 | -20.51 | -25.3 | -6.57 | |
| Change in Working Capital | -0.2 | 1.7 | 3.76 | 0.21 | -4.17 | -2.94 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.